AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹3,484 Cr | ₹3,169 Cr | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr |
What is the latest Profit After Tax of AUROBINDO PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹3,484 Cr |
| Mar2024 | ₹3,169 Cr |
| Mar2023 | ₹1,928 Cr |
| Mar2022 | ₹2,647 Cr |
| Mar2021 | ₹5,334 Cr |
How is Profit After Tax of AUROBINDO PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,484 Cr | 9.93 | |
| Mar2024 | ₹3,169 Cr | 64.40 | |
| Mar2023 | ₹1,928 Cr | -27.18 | |
| Mar2022 | ₹2,647 Cr | -50.37 | |
| Mar2021 | ₹5,334 Cr | - | |
Compare Profit After Tax of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹84,276.0 Cr | -2.5% | 3.1% | 28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.5% |
3.1% |
28.2% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses